Rapid start-up for early phase biotechs

The biotech drug development journey with Avance Clinical starts with robust early phase clinical foundations.

Avance Clinical’s ClinicReady is the surrogate or outsourced drug development team for preclinical biotechs. The ClinicReady scientific and regulatory affairs process supports demonstration of safety and preliminary clinical Proof of Concept (POC) and lays the vital clinical foundations that ensures seamless transition into phase one and beyond.

Our experienced team of professionals navigate biotechs through study design, protocol development, and regulatory requirements. From Phase I studies involving healthy volunteers or hybrid studies, to Phase II trials assessing initial efficacy in patient populations, the team plans around the specific needs and objectives of each trial and implements the most robust clinical processes.

Our partnership relationships with leading labs and Phase 1 units means early phase studies are seamlessly and rapidly implemented.

get in touch with our
clinical operations team

Delivering more than 30 years experience of drug development expertise

OUR EARLY PHASE CLINICAL TRIAL
EXPERTISE

The ClincReady team of experts

Start the early phase with your surrogate drug development team

Proven site network

Avance Clinical has a powerful network of proven PIs and clinical sites

World-class data

Avance Clinical data is accepted by all the major regulatory authorities including the FDA and EMA.

Phase 1 Units network

Avance Clinical offers a proven network of world-class Phase 1 Units

No IND required

In Australia our biotech clients start their Phase I without having to wait for an IND, saving up to a year in regulatory processing times and considerable costs.

5-6 week start-up

With the Site Initiation Visit (SIV) and Study Start achieved in 5 – 6 weeks it enables you to get access to clinical data quickly and gain that critical Go/No Go information on your product faster than anywhere else in the world.

43.5 % rebate

Biotechs can save 43.5% with the Australian Government’s attractive rebate to support clinical trials in Australia

WHY BIOTECHS CHOOSE
AVANCE CLINICAL

More than three decades of deep clinical research management experience, Avance Clinical is the largest
specialist Australian and US CRO delivering quality clinical trials in Australia, New Zealand, Asia and North America for international biotechs.

43.5%

REBATE

5-6 Wks

START-UP TIME

100%

CAPABILITIES

FDA

COMPLIANT RESEARCH